These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 23159963)

  • 1. SynchroMed II intrathecal pump memory errors due to repeated magnetic resonance imaging.
    Kosturakis A; Gebhardt R
    Pain Physician; 2012; 15(6):475-7. PubMed ID: 23159963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Magnetic fields and intrathecal pump malfunction.
    Huh B; Roldan CJ
    Am J Emerg Med; 2016 Jan; 34(1):115.e5-6. PubMed ID: 26008580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical safety of magnetic resonance imaging in patients with implanted SynchroMed EL infusion pumps.
    Diehn FE; Wood CP; Watson RE; Mauck WD; Burke MM; Hunt CH
    Neuroradiology; 2011 Feb; 53(2):117-22. PubMed ID: 20585763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The safety of magnetic resonance imaging in patients with programmable implanted intrathecal drug delivery systems: a 3-year prospective study.
    De Andres J; Villanueva V; Palmisani S; Cerda-Olmedo G; Lopez-Alarcon MD; Monsalve V; Minguez A; Martinez-Sanjuan V
    Anesth Analg; 2011 May; 112(5):1124-9. PubMed ID: 21474658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation between withdrawal symptoms and medication pump residual volume in patients with implantable SynchroMed pumps.
    Taha J; Favre J; Janszen M; Galarza M; Taha A
    Neurosurgery; 2004 Aug; 55(2):390-3; discussion 393-4. PubMed ID: 15271246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Malfunction of SynchroMed II baclofen pump delivers a near-lethal baclofen overdose.
    Sgouros S; Charalambides C; Matsota P; Tsangaris I; Kostopanagiotou G
    Pediatr Neurosurg; 2010; 46(1):62-5. PubMed ID: 20516743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fentanyl overdose caused by malfunction of SynchroMed II intrathecal pump: two case reports.
    Maino P; Koetsier E; Perez RS
    Reg Anesth Pain Med; 2014; 39(5):434-7. PubMed ID: 25075457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increasing back and radicular pain 2 years following intrathecal pump implantation with review of arachnoiditis.
    Kochany JZ; Tran ND; Sarria JE
    Pain Med; 2013 Nov; 14(11):1658-63. PubMed ID: 23889758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of intrathecal drug delivery system for refractory cancer pain patients: a single tertiary medical center experience.
    Lin CP; Lin WY; Lin FS; Lee YS; Jeng CS; Sun WZ
    J Formos Med Assoc; 2012 May; 111(5):253-7. PubMed ID: 22656395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of medically refractory cancer pain with a combination of intrathecal neuromodulation and neurosurgical ablation: case series and literature review.
    Bentley JN; Viswanathan A; Rosenberg WS; Patil PG
    Pain Med; 2014 Sep; 15(9):1488-95. PubMed ID: 24931480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implantable drug delivery systems (IDDS) after failure of comprehensive medical management (CMM) can palliate symptoms in the most refractory cancer pain patients.
    Smith TJ; Coyne PJ
    J Palliat Med; 2005 Aug; 8(4):736-42. PubMed ID: 16128647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrathecal baclofen withdrawal syndrome- a life-threatening complication of baclofen pump: a case report.
    Mohammed I; Hussain A
    BMC Clin Pharmacol; 2004 Aug; 4():6. PubMed ID: 15301690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implanted intrathecal drug delivery systems and radiation treatment.
    Gebhardt R; Ludwig M; Kirsner S; Kisling K; Kosturakis AK
    Pain Med; 2013 Mar; 14(3):398-402. PubMed ID: 23432925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An in vivo canine study to assess granulomatous responses in the MedStream Programmable Infusion System (TM) and the SynchroMed II Infusion System®.
    Michael A; Buffen E; Rauck R; Anderson W; McGirt M; Mendenhall HV
    Pain Med; 2012 Feb; 13(2):175-84. PubMed ID: 22239738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pontine hemorrhage following a recently implanted intrathecal drug delivery system.
    Rosenfeld DM; Trentman T; Patel NP
    Pain Pract; 2009; 9(4):312-6. PubMed ID: 19500275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intrathecal morphine pump for neuropathic cancer pain: a case report.
    Gogia V; Chaudhary P; Ahmed A; Khurana D; Mishra S; Bhatnagar S
    Am J Hosp Palliat Care; 2012 Aug; 29(5):409-11. PubMed ID: 21868426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrathecal narcotic infusion pumps for intractable pain of chronic pancreatitis: a pilot series.
    Kongkam P; Wagner DL; Sherman S; Fogel EL; Whittaker SC; Watkins JL; McHenry L; Lehman GA
    Am J Gastroenterol; 2009 May; 104(5):1249-55. PubMed ID: 19367269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive consensus based guidelines on intrathecal drug delivery systems in the treatment of pain caused by cancer pain.
    Deer TR; Smith HS; Burton AW; Pope JE; Doleys DM; Levy RM; Staats PS; Wallace MS; Webster LR; Rauck RL; Cousins M;
    Pain Physician; 2011; 14(3):E283-312. PubMed ID: 21587338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Massive clonidine overdose during refill of an implanted drug delivery device for intrathecal analgesia: a review of inadvertent soft-tissue injection during implantable drug delivery device refills and its management.
    Johnson ML; Visser EJ; Goucke CR
    Pain Med; 2011 Jul; 12(7):1032-40. PubMed ID: 21672143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety of active implantable devices during MRI examinations: a finite element analysis of an implantable pump.
    Büchler P; Simon A; Burger J; Ginggen A; Crivelli R; Tardy Y; Luechinger R; Olsen S
    IEEE Trans Biomed Eng; 2007 Apr; 54(4):726-33. PubMed ID: 17405380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.